畜牧兽医学报 ›› 2020, Vol. 51 ›› Issue (9): 2138-2146.doi: 10.11843/j.issn.0366-6964.2020.09.011

• 生物技术与繁殖 • 上一篇    下一篇

牦牛IGF-II干扰载体的构建及其转染对睾丸支持细胞的影响

张磊1, 阿果约达2, 谢拉准3, 吴锦波4, 李键1,2, 熊显荣1,2*   

  1. 1. 西南民族大学生命科学与技术学院, 成都 610041;
    2. 青藏高原动物遗传资源保护与利用国家教育部重点实验室, 成都 610041;
    3. 红原县科学技术和农业畜牧局, 阿坝 624400;
    4. 四川省阿坝州畜牧科学研究院, 阿坝 623000
  • 收稿日期:2020-03-23 出版日期:2020-09-25 发布日期:2020-09-25
  • 通讯作者: 熊显荣,主要从事牦牛细胞生物学和发育生物学研究,E-mail:xianrongxiong@163.com
  • 作者简介:张磊(1985-),女,湖北随州人,硕士,讲师,主要从事发育生物学研究,E-mail:1546138325@qq.com
  • 基金资助:
    国家“十三五”重点研发专项(2018YFD0502304);西南民族大学中央高校基本科研业务费专项资金项目(2019NQN45)

Construction of IGF-II shRNA Knockdown Vector and Its Effect on Sertoli Cells in Yak

ZHANG Lei1, AGUO Yueda2, XIE Lazhun3, WU Jinbo4, LI Jian1,2, XIONG Xianrong1,2*   

  1. 1. College of Life Science and Technology, Southwest Minzu University, Chengdu 610041, China;
    2. Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization of Ministry of Education, Chengdu 610041, China;
    3. Agriculture and Animal Husbandry Science and Technology Bureau of Hongyuan County, Aba 624400, China;
    4. Animal Husbandry Science Institute of Aba Autonomous Prefecture, Aba 623000, China
  • Received:2020-03-23 Online:2020-09-25 Published:2020-09-25

摘要: 旨在构建干扰胰岛素样生长因子(insulin-like growth factor-II,IGF-II)的重组质粒载体,研究IGF-II对牦牛睾丸支持细胞的影响。本研究设计并合成针对牦牛IGF-II的shRNA寡核苷酸,并将其克隆至pLKO.1质粒载体上,转染牦牛睾丸支持细胞后经嘌呤霉素筛选获得稳定的细胞株,并采用实时荧光定量PCR(qRT-PCR)和蛋白免疫印迹法检测IGF-II基因和蛋白的表达,采用细胞生长分析仪分析支持细胞的增殖凋亡情况。结果显示,干扰牦牛IGF-II表达的pLKO.1质粒载体构建成功,其可在睾丸支持细胞中稳定表达,且能有效抑制IGF-II基因的表达。与对照组相比,pLKO.1-shRNA2的干扰效率最显著,IGF-Ⅱ的表达量下调至19.1%(P<0.05),且pLKO.1-shRNA2可使内源性IGF-II蛋白的表达量减少76.3%(P<0.05)。pLKO.1-shRNA2质粒转染及筛选得到的稳定细胞株培养48 h后的细胞分裂增殖活性显著低于对照组(P<0.05)。qRT-PCR结果显示,干扰内源性IGF-II后,睾丸支持细胞中的IGF-I和IGF-IIR基因表达出现了显著的上调(P<0.05),IGF-IR与Bcl-2的表达出现了显著的下调(P<0.05)。综上表明,牦牛IGF-II干扰质粒构建成功,其转染至牦牛睾丸支持细胞有效抑制了IGF-II的表达,改变了IGF-IR与Bcl-2的表达模式,潜在影响了牦牛支持细胞的分裂增殖,具体作用机制有待进一步研究。

关键词: 牦牛, 支持细胞, IGF-II, 干扰, 细胞增殖

Abstract: The aim of this study was to construct shRNA recombinant vector interfering insulin-like growth factor-II (IGF-II), and study the effects of IGF-II on the yak sertoli cells. The shRNA oligonucleotides targeting yak IGF-II were designed and synthesized and it was cloned into pLKO.1 plasmid vector, after transfected into yak sertoli cells, a stable cell line was obtained by puromycin selection. The relative expressions of IGF-II mRNA and protein were identified by qRT-PCR and Western blotting, respectively. The proliferation and apoptosis of sertoli cells were analyzed by proliferation measurement system. The results showed that the pLKO.1-shRNA vector interfering IGF-II was successfully constructed, which was stably expressed in sertoli cells and could interfere the expression of yak IGF-II effectively. Compared with the control group, the interference efficiency of pLKO.1-shRNA2 was the most significant, IGF-II expression down-regulated to 19.1% (P<0.05), and could reduce the expression of endogenous IGF-II protein by 76.3% (P<0.05). The stable cell line obtained by transfection and screening of pLKO.1-shRNA2 plasmid had significant lower activity of cell division and proliferation than that of control group after 48 h of culture (P<0.05). The results of qRT-PCR showed that the expressions of IGF-I and IGF-IIR in sertoli cells were significantly up-regulated (P<0.05), and the expressions of IGF-IR and Bcl-2 were significantly down-regulated (P<0.05) after interfering IGF-II. In conclusion, the interference plasmids of IGF-II were successfully constructed. After interference plasmid was transfected into yak sertoli cells, it could effectively inhibit the expression of IGF-II, change the expression pattern of IGF-IR and Bcl-2, and potentially affect the division and proliferation of yak sertoli cells, however, the specific regulation mechanism requires further studied.

Key words: yak, sertoli cells, IGF-II, interfere, cell proliferation

中图分类号: